The Geraldine Weiss dividend yield theory applied to Hikma Pharmaceuticals PLC ($HKMPF) uses the stock's historical dividend yield range to estimate when the price is cheap or expensive relative to its own dividend-paying history (2016–2026). Based on that history, $HKMPF is currently trading close to its fair value.

When the $HKMPF yield climbs above 🟢 4.4%, the stock has historically been undervalued. When the yield falls below 🔴 0.82%, Hikma Pharmaceuticals PLC has historically been overvalued. The dashed 🟡 fair value (~2.61%) line marks the orientative midpoint between both extremes, not a price target.